ACE Report Cover
Multi-level degenerative disc disease: TDR with Mobi-C artificial disc compared to ACDF
Translate this  ACE Report Translate this  ACE Report Translate this  ACE Report
Lingua
Download Download Download
Scaricare
Cite this Report Cite this Report Cite this Report
Citare
Add to Favorites Add to Favorites Add to Favorites Remove from Favorites Remove from Favorites Remove from Favorites
+ Preferiti
Translate this  ACE Report Translate this  ACE Report Translate this  ACE Report
Lingua
Download Download Download
Scaricare
Cite this Report Cite this Report Cite this Report
Citare
Add to Favorites Add to Favorites Add to Favorites Remove from Favorites Remove from Favorites Remove from Favorites
+ Preferiti
SPINE
Multi-level degenerative disc disease: TDR with Mobi-C artificial disc compared to ACDF .
Verified
This report has been verified by one or more authors of the original publication.
High Impact
Questo studio è stato identificato come potenzialmente ad alto impatto. La metrica High Impact di OE, guidata dall'AI, stima l'influenza che un articolo potrebbe avere integrando i segnali della rivista in cui è stato pubblicato e il contenuto scientifico dell'articolo stesso. Sviluppato utilizzando un'elaborazione del linguaggio naturale all'avanguardia, il modello High Impact di OE prevede in modo più accurato la futura performance citazionale di uno studio rispetto al solo fattore di impatto della rivista. Ciò consente di riconoscere prima le ricerche clinicamente significative e aiuta i lettori a concentrarsi sugli articoli che hanno maggiori probabilità di influenzare la pratica futura.

OrthoEvidence Journal (OE Journal) - ACE Report

OE Journal. 2014;2(3):22 J Neurosurg Spine. 2013 Nov;19(5):532-45

330 patients suffering from cervical degenerative disc disease (DDD) with radiculopathy or myeloradiculopathy at 2 contiguous levels from C-3 to C-7 were randomized to investigate the benefits of cervical total disc replacement (TDR) using the Mobi-C cervical device (LDR Spine) compared with conventional anterior cervical discectomy and fusion (ACDF). The evidence presented in this study indicated that TDR demonstrated statistical superiority over ACDF based on overall study success rates: both TDR and ACDF groups experienced significant improvements in Neck Disability Index (NDI) score, and VAS neck and arm pain at all time points; however TDR patients demonstrated significantly superior NDI scores at all time points compared to ACDF patients, along with significantly superior VAS neck pain at only 3 and 6 months. TDR group maintained preoperative segmental range of motion at both treated segments immediately postoperatively and throughout the study period. Finally, reoperations were significantly higher in the ACDF group compared to the TDR group.


Dettagli sul finanziamento della pubblicazione +
Finanziamento:
Industry funded
Sponsor:
LDR Medical
Conflitti:
Other

Rischio di pregiudizio

6/10

Criteri di segnalazione

15/20

Indice di fragilità

N/A

Was the allocation sequence adequately generated?

Was allocation adequately concealed?

Blinding Treatment Providers: Was knowledge of the allocated interventions adequately prevented?

Blinding Outcome Assessors: Was knowledge of the allocated interventions adequately prevented?

Blinding Patients: Was knowledge of the allocated interventions adequately prevented?

Was loss to follow-up (missing outcome data) infrequent?

Are reports of the study free of suggestion of selective outcome reporting?

Were outcomes objective, patient-important and assessed in a manner to limit bias (ie. duplicate assessors, Independent assessors)?

Was the sample size sufficiently large to assure a balance of prognosis and sufficiently large number of outcome events?

Was investigator expertise/experience with both treatment and control techniques likely the same (ie.were criteria for surgeon participation/expertise provided)?

Sì = 1

Incerto = 0,5

Non rilevante = 0

No = 0

La valutazione dei criteri di segnalazione valuta la trasparenza con cui gli autori riportano le caratteristiche metodologiche e sperimentali dello studio all'interno della pubblicazione. La valutazione è suddivisa in cinque categorie che vengono presentate di seguito.

2/4

Randomization

2/4

Outcome Measurements

3/4

Inclusion / Exclusion

4/4

Therapy Description

4/4

Statistics

Detsky AS, Naylor CD, O'Rourke K, McGeer AJ, L'Abbé KA. J Clin Epidemiol. 1992;45:255-65

L'Indice di Fragilità è uno strumento che aiuta l'interpretazione dei risultati significativi, fornendo una misura della forza di un risultato. L'Indice di Fragilità rappresenta il numero di eventi consecutivi che devono essere aggiunti a un risultato dicotomico per rendere il risultato non più significativo. Un numero piccolo rappresenta un risultato più debole, mentre un numero grande rappresenta un risultato più forte.

Perché questo studio era necessario ora?

Anterior cervical discectomy and fusion (ACDF) is considered ‘gold standard’ in treating neurological symptoms and neck pain associated with degeneration of intervertebral discs in the cervical spine. ACDF is however associated with hypermobility, increased stress, and increased intradiscal pressures on the segments adjacent to fused level. Cervical total disc replacement (TDR) is an attractive alternative as it addresses the limitations of ACDF by preserving biomechanics at the adjacent segments, allowing for slower degeneration and reduced pain and neurological symptoms. The current research pertaining to the optimal intervention for degenerative disc disease (DDD) remains controversial, especially as the relevant trials have compared TDR and ACDF only at a single level. Multilevel pathologies tend to be more demanding and therefore this study was needed to compare TDR (Mobil-C cervical artificial disc; LDR Medical) against ACDF for symptomatic cervical DDD at 2 contiguous levels of the cervical spine.

Qual era la domanda di ricerca principale?

Is there a superior method of fixation for multi-level degenerative disc disease (DDD) between total disc replacement (TDR) with the Mobi-C cervical artificial disc, and anterior cervical discectomy and fusion, as evaluated over 24 months?

Caratteristiche dello studio +
Population:
330 patients suffering from degenerative disc disease (DDD) with radiculopathy or myeloradiculopathy at 2 contiguous levels from C-3 to C-7, that was not responsive to nonoperative interventions for at least 6 weeks or that exhibited progressive symptoms.
Intervention:
TDR Group: Patients in this group were fitted with the Mobi-C cervical artificial disc which allows for 5 independent degrees of freedom: 2 translational and 3 rotational. The device is designed for multilevel applications by eliminating features such as keels, screws, or protruding hardware. All surgeries were performed through a Smith-Robinson anterior approach to the cervical spine, and all patients underwent a thorough discectomy at both index levels. Subsequently, the disc space was distracted in parallel using a vertebral distractor; the appropriate implant footprint and height were selected and the prosthesis was inserted into the disc space. (n= 225, 98.2% followed-up at 24 months; Mean Age: 45.3 +/- 8.10 years; M/F= 113/112).
Comparison:
ACDF Group: Patients in this group were administered a corticocancellous allograft and an anterior cervical plate using the standard ACDF technique (either the Slim-Loc Anterior Cervical Plate System; Depuy, Sofamor Danek Atlantis or the Atlantis Vision Anterior Cervical Plate Systems; Medtronic). All surgeries were performed through a Smith-Robinson anterior approach to the cervical spine, and all patients underwent a thorough discectomy at both index levels. Postoperative care included the use of a cervical collar, physical therapy, pain medications, and/or alternative methods.(n= 105, 94.3% followed-up at 24 months; Mean Age: 46.2 +/- 7.99 years; M/F= 45/60).
Outcomes:
Primary Endpoint: A composite measure evaluating overall study success rate consisting of: Neck Disability Index; no subsequent surgical intervention at the index level(s); no adverse events (evaluated by the Clinical End Points Committee; CEC) as major complications; maintenance or improvement in neurological function; and radiographic success. Criteria for success in each outcome is defined in the original publication.
Methods:
RCT: Multi-Centered (24 sites)
Time:
Patients assessed preoperatively; 6 weeks after surgery; and at 3, 6, 12, 18, and 24 months after surgery.
Quali erano i risultati importanti?
  • The overall clinical success rate in the TDR group was 69.7% compared to 37.4% in the ACDF group (p< 0.05). TDR patients achieved success earlier than the ACDF patients, and maintained it throughout the study.
  • Patients in both the TDR and ACDF groups exhibited a marked improvement from baseline in VAS neck (mean change at 24 months: 54 +/- 25 and 53 +/- 29 respectively) and arm pain (mean change at 24 months: 35 +/- 35 and 34 +/- 38 respectively) at all time points. VAS neck pain scores in TDR patients were significantly superior at 3 and 6 months compared to ACDF patients (p< 0.05).
  • Mean change in NDI score at 24 months in the TDR group was 37 +/- 20 compared to 30 +/- 19 in the ACDF group. Both groups improved significantly from baseline but the TDR group demonstrated significantly greater scores at every time point compared to the ACDF group. NDI success was significantly higher in the TDR group at all time points (p< 0.05) with 78.2% of TDR patients compared to 61.8% ACDF patients considered a success at 24 months.
  • SF-12 evaluations of TDR patients indicated a mean improvement on the physical (PCS) and mental component (MCS) of 13.5 and 9.5 respectively compared to 10.5 and 7.2 in ACDF patients (p= 0.03 at 24 in favor of TDR).
  • 7 (3.1%) TDR patients required a subsequent surgical intervention through 24 month's follow-up (4 removals, 2 reoperations, and 1 revision) compared to 12 (11.4%) of ACDF patients (6 removals; 1 revision; 3 supplemental fixations; and 2 reoperations).
  • TDR patients exhibited significantly lower incidence of device-related adverse events with rates of 16.7% (39 of 225 patients) compared to 34.3% (36 of 105 patients) in the ACDF group. 23.9% of TDR patients experienced at least 1 serious adverse event compared to 32.4% ACDF patients; however only 3.4% (8) in the TDR and 14.3% (15) in the ACDF cohorts were definitely or possibly related to the device. Overall 3.6% of TDR patients had major complications with an adverse event compared to 6.7% of ACDF patients.
  • 5.6% of TDR patients compared to 6.7% of ACDF groups exhibited significant neurological deterioration. This difference was significantly in favor of TDR (p< 0.0001). TDR patients demonstrated significantly superior radiographic success (p< 0.0001): 96.4% of TDR group patients were classified as radiographically successful compared to 79.8% of ACDF group patients. Differences in adjacent-level degeneration rates were significant in favor of the TDR group for both levels at 12 and 24 month follow-ups (p< 0.03).
  • 95.8% of TDR patients were satisfied with their treatment compared to 92.0% of ACDF patients, and 95.8% TDR patients would recommend the surgery to a friend compared to 88.5% ACDF patients.
Che cosa devo ricordare di più?

Patients in both the cervical total disc replacement (TDR) and anterior cervical discectomy and fusion (ACDF) experienced significant improvements in neck pain, arm pain and disability at all time points. Total disc replacement patients demonstrated significantly superior NDI scores at all time points compared to ACDF patients, along with significantly superior neck pain in the short term (at 3 and 6 months). Total disc replacement patients maintained preoperative segmental range of motion at both treated segments immediately postoperatively and throughout the study period. Reoperations were significantly higher in the ACDF group compared to the total disc replacement group, and the incidence of adjacent-segment degeneration was significantly lower in the TDR group.

Come influenzerà l'assistenza ai miei pazienti?

The evidence presented in this study demonstrated the noninferiority and potential superiority of cervical total disc replacement using the Mobi-C cervical artificial disc compared with conventional anterior cervical discectomy and fusion in treatment multi-level degenerative cervical disc disease. While the results presented in this study are promising, controversy still remains about differential efficacy between these treatments over an extended period of time. Long-term evaluation of the Mobi-C cervical disc is required to determine if the benefits observed in this trial are maintained, or lost over a longer time frame.

DISCLAIMER

Il contenuto di questa pagina è solo a scopo informativo e non intende sostituire la consulenza, la diagnosi o il trattamento medico professionale. Se ha bisogno di cure mediche, si rivolga sempre al suo medico o al pronto soccorso più vicino. Le opinioni, le convinzioni e i punti di vista espressi dalle persone sui contenuti presenti in questa pagina non riflettono le opinioni, le convinzioni e i punti di vista di OrthoEvidence.

0 di 4 articoli mensili GRATUITI sbloccati
Ha raggiunto il suo limite di 4 visualizzazioni di articoli gratuiti questo mese

Accesso a OrthoEvidence a soli 1,99 dollari a settimana.

Rimanga in contatto con le ultime prove. Può disdire in qualsiasi momento.
  • Valutazioni critiche dei più recenti studi randomizzati controllati ad alto impatto e delle revisioni sistematiche in ortopedia.
  • Accesso ai contenuti del podcast OrthoEvidence, tra cui collaborazioni con il Journal of Bone and Joint Surgery, interviste con chirurghi di fama internazionale e tavole rotonde su notizie e argomenti ortopedici.
  • Abbonamento a The Pulse, una newsletter bisettimanale basata sulle evidenze scientifiche, progettata per aiutarla a prendere decisioni cliniche migliori.
Upgrade
Close Dialog
Bentornato!
Ha dimenticato la password?
Inizi la sua prova gratuita oggi stesso!

Il suo account sarà affiliato a
e includerà l'accesso gratuito a OrthoEvidence


O
Ha dimenticato la password?

O
Controlli la sua e-mail

Se esiste un account con l'indirizzo e-mail fornito, le verrà inviata un'e-mail di reimpostazione della password. Se non vede l'e-mail, controlli la cartella spam o posta indesiderata.

Per ulteriore assistenza, contatti il nostro team di supporto.

Effettui il login per abilitare questa funzione

Per accedere a questa funzione, deve essere collegato ad un account OrthoEvidence attivo. Effettui il login o crei un account di prova GRATUITO.

Tradurre il Rapporto ACE

OrthoEvidence utilizza un servizio di traduzione di terze parti per rendere i contenuti accessibili in più lingue. Si prega di notare che, sebbene venga fatto ogni sforzo per garantire l'accuratezza, le traduzioni potrebbero non essere sempre perfette.

Come citare questo documento ACE Report

OrthoEvidence. Multi-level degenerative disc disease: TDR with Mobi-C artificial disc compared to ACDF. OE Journal. 2014;2(3):22. Available from: https://myorthoevidence.com/AceReport/Show/multi-level-degenerative-disc-disease-tdr-with-mobi-c-artificial-disc-compared-to-acdf

Copiare la citazione
Effettui il login per abilitare questa funzione

Per accedere a questa funzione, deve essere collegato ad un account OrthoEvidence attivo. Effettui il login o crei un account di prova GRATUITO.

Funzionalità per i membri Premium

Per accedere a questa funzione, deve essere collegato ad un account OrthoEvidence Premium.

Condividi questo articolo ACE Report